TWST
Twist Bioscience Corp
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$153.44
−11.54%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 18.54x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 22.82x
- Price / sales
- 23.56x
- Price / cash flow
- -191.68x
Enterprise value
- Enterprise value
- $10.1B
- EV / sales
- 23.39x
- EV / EBITDA
- -93.70x
- EV / EBIT
- -73.31x
- Market cap
- $10.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026